HUMAN ARGINASE AND PEGYLATED HUMAN ARGINASE AND APPLICATION THEREOF

• 1. 人精氨酸酶和聚乙二醇化人精氨酸酶及其应用 [P] . 中国专利： CN103184209B . 2015.09.16
• 2. 人精氨酸酶和定点聚乙二醇化人精氨酸酶及其应用 [P] . 中国专利： CN103184208B . 2015.09.16
• 3. HUMAN ARGINASE AND PEGYLATED HUMAN ARGINASE AND APPLICATION THEREOF [P] . 欧洲知识产权局专利： EP2799540A4 . 2015-08-26

  机译： 人精氨酸酶和聚乙二醇人精氨酸酶及其应用

• 4. HUMAN ARGINASE AND PEGYLATED HUMAN ARGINASE AND APPLICATION THEREOF [P] . 韩国专利： KR20140107616A . 2014-09-04

  机译： 人精氨酸酶和聚乙二醇人精氨酸酶及其应用

• 5. HUMAN ARGINASE AND PEGYLATED HUMAN ARGINASE AND APPLICATION THEREOF [P] . 欧洲知识产权局专利： EP2799540A1 . 2014-11-05

  机译： 人精氨酸酶和聚乙二醇人精氨酸酶及其应用

• 1. Immunohistochemical panel of glypican-3, hepatocyte paraffin antigen-1, arginase-1, cytokeratin-19, and human epithelial membrane antigen for the differential diagnosis of liver tumors [J] . Dongling Zhu, Dong Kuang, Sijuan Zou, 肿瘤学与转化医学（英文） . 2019,第004期
• 2. Immunohistochemical panel of glypican-3, hepatocyte paraffin antigen-1, arginase-1, cytokeratin-19, and human epithelial membrane antigen for the differential diagnosis of liver tumors* [J] . Dongling Zhu, Dong Kuang, Sijuan Zou, 中德临床肿瘤学杂志（英文版） . 2019,第004期
• 3. Application of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) for the prevention of neutropenia in triple negative breast cancer patients older than 65 years during adjuvant chemotherapy [J] . Shuxian Qu, Jianing Qiu, Yidan Zhang, 肿瘤学与转化医学（英文） . 2019,第005期
• 4. Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells [J] . Zhuyun Zhao, Peng Zhang, Wei Li, Oxidative Medicine and Cellular Longevity . 2021,第a期
• 5. Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma [J] . Yau Thomas, Cheng Paul N., Chan Pierre, Investigational new drugs. . 2015,第2期
• 6. A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma [J] . YauT., ChengP.N., ChanP., Investigational new drugs. . 2013,第1期
• 7. Enzyme Activity Assay of a PEGylated Arginase in Mouse Serum Using LC-MS/MS [C] . Oanh Dang, Susan Alters, Scott Rowlinson, ASMS Conference on Mass Spectrometry and Allied Topics . 2015
• 8. Structural studies of two related metallohydrolases: human histone deacetylase 8 and malarial arginase [D] . Dowling, Daniel Peter 2009
• 9. Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells [O] . Zhuyun Zhao, Peng Zhang, Wei Li, 2021
• 10. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion [O] . Cheng, PNM, Lam, TL, Lam, WM, 2007

• 1. A New Bi-enzyme Potentiometric Sensor for Arginine Analysis Based on Recombinant Human Arginase I and Commercial Urease [J] . Nataliya Stasyuk ,Oleh Smutok ,Galina Gayda . 材料科学与工程：中英文A版 . 2011,第6期
• 2. Induction of Human Anti-Human Antibody Responses (Ab2) after Application of a Humanized Lewis Y Carbohydrate Specific Antibody (Ab1): Connection of Prolonged Disease Stabilization with Ab3 Induction? [J] . Andreas Nechansky ,Stefan Stranner ,Oliver Scheiber . 癌症治疗（英文） . 2012,第4期
• 3. 人Ⅰ型精氨酸酶的固定化及其制备L-鸟氨酸的方法研究 [C] . 张雪 ,马立新 . 第十一届中国酶工程学术研讨会 . 2017
• 4. 人精氨酸酶与人的血清蛋白融合蛋白在毕赤酵母中的表达及活性测定 [A] . 岳瑛 . 2010